Turkey’s Zer Recognized as “Product Challenger” in Global Procurement Ecosystem
4.4.2022 12:00:00 EEST | Business Wire | Press release
Zer , a Turkey-based company specializing in strategic procurement and sourcing management, has been included – for the first time – on the prestigious Provider Lens™ Quadrant Report of Information Services Group (ISG), a leading global technology research and advisory firm. Updated on a quarterly basis, ISG Provider Lens™ is a practitioner-led service provider comparison, empowered by ISG’s advisory experience and data-driven research.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220401005382/en/
For the first time, Turkish procurement services firm Zer has been listed on ISG’s Provider Lens™ Quadrant Report (Photo: Business Wire)
A subsidiary of Turkey's Koç Group, Zer took its place in ISG Provider Lens™ report in both the “Procurement BPO Services” and the “Digital Transformation Services” quadrants for both large accounts and midmarket categories. Zer featured in the same quadrant with the firms who consult to industry giants on Fortune 50.
Zer's brand Promena, which is a strategic procurement software, meanwhile, also made the list (in the “Software Platforms and Solutions” quadrant for large accounts), taking a place alongside globally-recognized service providers.
‘Closely followed by procurement professionals’
According to Zer General Manager Mehmet Apak, ISG’s Provider Lens List is extremely influential in the competitive world of digital solutions. “It is closely followed by supply chain and procurement professionals from all over the world,” Apak says. “Lists like ISG Provider Lens™ serve to raise brand awareness in international markets and enhance Turkey's role in the global procurement ecosystem.”
Underlining that global demand for Promena had recently increased by 50%, Apak went on to assert that “Zer’s inclusion in the ISG Provider Lens™ “is a natural reflection of the qualities we bring to all stakeholders – qualities such as resilience and agility.” Both these qualities are crucial, he adds, “in a business environment that is increasingly unpredictable and in which priorities are constantly changing.”
A ‘Value Leader’ in the global procurement sector
Zer‘s strategic procurement software Promena has also been recognized by SpendMatters, Capgemini, Capterra, Procurement Leaders, Art of Procurement and Sourceforge, all of which follow top digital solutions and procurement brands. Since 2019, Promena was included in SpendMatters’ influential Solutionmap Report. Last year, the same report described the company as a “Value Leader” in the global procurement sector.
“We’re pleased that our company is drawing international attention,” Apak says. “In the digital age, procurement and supply chain management is more essential than ever. It lets businesses connect with the rest of the world, keep costs and risks in check, and overcome the hurdles associated with digital transformation.”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220401005382/en/
Contact information
Tülay Genç
support@b2press.com
+90 (212) 635 70 68
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Estithmar Holding Pays the Third Semi-Annual coupon of the 8.75% Sukuk Tranche12.3.2026 22:50:00 EET | Press release
Estithmar Holding Q.P.S.C. has paid the third semi-annual coupon of its Qatari Riyal-denominated Sukuk (first tranche), at an annual profit rate of 8.75%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312880092/en/ Estithmar Holding Pays the Third Semi-Annual coupon of the 8.75% Sukuk Tranche (Photo: AETOSWire) The first tranche, part of the company’s broader Sukuk program valued at QAR 3.4 billion and listed on the London Stock Exchange’s International Securities Market, was issued in August 2024. The issuance attracted a diverse pool of institutional investors including banks, insurance companies, and asset managers, with strong interest from both government-affiliated and private institutions. This demand reflects growing investor confidence in Estithmar Holding’s ability to deliver sustained value to stakeholders. EstithmarHolding was recently included in the FTSE Russell Global Equity Index, in Qatar’s Mid-Cap segme
REPLY: The Board of Directors Approved the Draft Financial Statements for the Year 202512.3.2026 16:38:00 EET | Press release
Today the Board of Directors of Reply S.p.A. [MTA, STAR: REY] approved the draft financial statement for the year 2025, which will be submitted for approval to the Shareholders’ Meeting to be held in first call in Turin on 23 April 2026. The Reply Group closed 2025 with a consolidated turnover of €2,483.6 million, an increase of 8.0% compared to €2,300.5 million in 2024. All indicators are positive for the period. Consolidated EBITDA was €467.6 million, an increase of 13.9% compared to €410.6 million at December 2024. EBIT, from January to December, was at €391.7 million, which is an increase of 18.5% compared to €330.4 million at December 2024. The Group net profit was at €250.9 million. In 2024, the corresponding value was €211.1 million. Following the results achieved in 2025, the Reply Board of Directors decided to propose to the next Shareholders’ Meeting a dividend distribution of €1.35 per share, which will be payable on 20 May 2026, with dividend date set on 18 May 2026 (record
LZE GmbH Introduces Fraunhofer’s RFicient® Technology to the Market12.3.2026 15:51:00 EET | Press release
LZE GmbH is expanding its technology transfer portfolio and making the RFicient® ultra-low-power wake-up receiver technology from the Fraunhofer Institute for Integrated Circuits IIS available for the first time as a standard chip for close-to-production industrial applications. The solution enables energy-efficient IoT designs that remain continuously reachable while consuming only microamps – a key step for long-lasting, low-maintenance IoT products. LZE GmbH drives technology transfer to market: standard chip availability for close-to-production applications As a bridge between research and industry, LZE GmbH is making it easier for companies to access innovative technologies and helping them to quickly and reliably transform new developments into market-ready solutions. With RFicient®-IC (FH101RF), LZE is providing another high-tech product that comes directly from Fraunhofer research and can now be ordered in volume and integrated into close-to-production product development for t
Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing12.3.2026 15:30:00 EET | Press release
Owkin, the AI company on a mission to solve the complexity of biology, today announced the spin out of Waiv, formerly known as Owkin Dx. The move follows significant investor interest and positions Waiv to bring AI-powered precision testing for better identification of patients in the clinic and in clinical trials, to transform patient care. This follows on from the successful launch of Bioptimus, an Owkin incubated company, in February 2024. Waiv translates AI innovation into real-world clinical impact, developing tests that predict biomarkers and patient outcomes, including RlapsRisk BC for prognostic risk profiling. With multiple tests already in use in clinical settings, its deployment platform Destra, and collaborations with leading pharmaceutical companies, including MSD since 2023 for MSIntuit, Waiv is establishing itself as a leader in translational medical AI. Waiv leverages a decade of Owkin's foundational medical AI research, including access to an extensive patient data net
RQM+ Launches SMART Solutions Life Cycle Partnership Model12.3.2026 15:30:00 EET | Press release
RQM+, a leading MedTech CRO offering regulatory consulting, clinical trial, laboratory, and reimbursement services, today announced the launch of SMART Solutions, a life cycle partnership model designed to help medical device and diagnostics companies manage growing regulatory and development complexity. SMART Solutions introduces a strategy-led operating framework that unifies regulatory, quality, clinical, reimbursement, and laboratory expertise to support MedTech companies across the entire product life cycle to help reduce risk from early development through post-market. “MedTech companies are navigating unprecedented complexity as regulatory expectations evolve, product innovation accelerates, and post-market expectations are expanding,” said John Potthoff, Ph.D., chief executive officer of RQM+. “SMART Solutions moves beyond traditional consulting by providing an integrated life cycle partnership that helps sponsors gain earlier clarity, reduce risk, and execute complex programs
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
